A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome

por Clayton, P, Chatelain, P, Tatò, L, Yoo, H W, Ambler, G R, Belgorosky, A, Quinteiro, S, Deal, C, Stevens, A, Raelson, J, Croteau, P, Destenaves, B, Olivier, C
Publicado 2013

Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before...

por Abraham, M B, Nicholas, J A, Ly, T T, Roby, H C, Paramalingam, N, Fairchild, J, King, B R, Ambler, G R, Cameron, F, Davis, E A, Jones, T W
Publicado 2016

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome

por Stevens, A, Clayton, P, Tatò, L, Yoo, H W, Rodriguez-Arnao, M D, Skorodok, J, Ambler, G R, Zignani, M, Zieschang, J, Della Corte, G, Destenaves, B, Champigneulle, A, Raelson, J, Chatelain, P
Publicado 2014